Last reviewed · How we verify
NCT03257059: BEGIN
Breakfast Consumption and Its Effects on Glycemic, Insulinemic and Non-Esterified Fatty Acids Responses
NA trial testing Breakfast in Glycemic Response in 13 participants. Completed in 28 March 2019.
28 March 2019
Quick facts
| Lead sponsor | JeyaKumar Henry |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | other |
| Enrollment | 13 |
| Start date | 25 July 2017 |
| Primary completion | 28 March 2019 |
| Estimated completion | 28 March 2019 |
| Sites | 1 location across Singapore |
Drugs / interventions tested
- Breakfast
- No Breakfast
Conditions studied
- Glycemic Response — all drugs for Glycemic Response →
Sponsor
JeyaKumar Henry
Who can join
Adults 40 to 65, male only, with Glycemic Response. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to determine whether eating breakfast or having no breakfast has subsequent beneficial health effects, specifically in relation to glycemic response throughout the day and postprandial insulin and non-esterified fatty acids (NEFA) responses 6 hours after breakfast/lunch.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effect of breakfast on weight and energy intake: systematic review and meta-analysis of randomised controlled trials.
Sievert K, Hussain SM, Page MJ, Wang Y, et al · · 2019 · cited 109× · PMID 30700403 · DOI 10.1136/bmj.l42
Verify or expand the search:
- PubMed search for NCT03257059
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Breakfast
Trials testing the same drug.
- NCT06821620 — Interaction of MTNR1B Genotype and Type of Breakfast (Protein-enriched v Carbohydrate-rich) on Postprandial Glucose Resp · NA · completed
- NCT05986097 — The Breakfast Study · Phase 1, PHASE2 · completed
- NCT05414474 — Effects of Enhancers and Inhibitors on Absorption From Iron Supplements · NA · completed
- NCT06546657 — Glucose Variability in Type 1 Diabetes (T1D) and Glycaemic Responses to Food Composition. · completed
- NCT03146442 — Increased Protein at Breakfast for Weight Management in Overweight Adolescents · NA · completed
Other recruiting trials for Glycemic Response
Currently open trials in the same condition.
- NCT04881019 — PRediction Of Glycemic RESponse Study · active not recruiting
Other JeyaKumar Henry trials
Trials by the same sponsor.
- NCT03964857 — Blended Oil Beneficial for Blood Lipids Management · NA · unknown
- NCT03279107 — Effects of Different Types of Carbohydrates in Snacks and Beverages on Glycemia, Insulinemia and Appetite. · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03257059 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by JeyaKumar Henry
- Last refreshed: 13 May 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03257059.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing